Australia cannot rely on overseas vaccines remaining effective and needs a “backup”, say authorities, who have awarded $1.6 million to a trial to fight the ‘new COVID-19 strain’.
By mid-2021, volunteers aged between 18 and 75 years will be recruited for an ‘accelerated clinical trial’ of two “next generation” vaccines, developed by the University of Melbourne.
[…Continued]